Prostatype Genomics TO6 warrant trading ends as exercise window nears close

PUBT · 2d ago
Prostatype Genomics TO6 warrant trading ends as exercise window nears close
  • Trading in TO6 warrants ends tomorrow, Sept. 11, 2026; holders must sell by then or risk expiry.
  • Exercise window runs through Sept. 15, 2026; each TO6 warrant subscribes for one new share at SEK 0.1.
  • Up to 125,225,546 shares could be issued; gross proceeds about SEK 12.5 million before issue costs.
  • Subscription commitments, letters of intent, underwriting total about SEK 8.7 million, or roughly 70% of the maximum volume.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prostatype Genomics AB published the original content used to generate this news brief on September 10, 2026, and is solely responsible for the information contained therein.